Therapeutic Advances in Respiratory Disease
Scope & Guideline
Elevating Standards in Pulmonary Research
Introduction
Aims and Scopes
- Clinical Research in Respiratory Diseases:
The journal publishes original research on various respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and infections, emphasizing clinical trials and observational studies. - Innovative Therapeutic Approaches:
It highlights studies on novel therapeutic interventions, including pharmacological treatments, biologics, and advanced medical technologies such as robotic-assisted bronchoscopy and endobronchial ultrasound. - Diagnostic Advances:
Research focusing on novel diagnostic methods and biomarkers for respiratory diseases is a key area, including studies on imaging techniques, molecular diagnostics, and the validation of clinical assessment tools. - Patient-Centered Outcomes:
The journal places a strong emphasis on patient-reported outcomes, quality of life assessments, and the psychosocial aspects of living with respiratory diseases, aiming to incorporate patient perspectives into clinical practice. - Epidemiology and Public Health:
It includes epidemiological studies that analyze the prevalence, risk factors, and burden of respiratory diseases in various populations, providing insights into public health implications.
Trending and Emerging
- Personalized Medicine and Biomarkers:
There is a growing focus on personalized treatment strategies and the identification of biomarkers that guide therapy, particularly in complex diseases like asthma and COPD, highlighting the importance of individualized patient care. - Impact of COVID-19 on Respiratory Health:
Research examining the long-term effects of COVID-19 on respiratory health, including post-acute sequelae and rehabilitation strategies, has seen a significant rise, reflecting an urgent need for addressing the pandemic's implications. - Interventional Pulmonology Techniques:
Emerging interest in advanced interventional techniques such as endobronchial ultrasound and robotic bronchoscopy is evident, showcasing the journal's commitment to reporting on innovative procedures that enhance diagnostic and therapeutic capabilities. - Telemedicine and Digital Health Solutions:
The incorporation of telemedicine and digital health solutions into respiratory disease management is trending, with studies focusing on their effectiveness in improving access to care and patient outcomes during and after the COVID-19 pandemic. - Multidisciplinary Approaches to Treatment:
There is an increasing emphasis on multidisciplinary care models that integrate various specialties to address the complex needs of patients with respiratory diseases, reflecting a holistic approach to treatment.
Declining or Waning
- Traditional Therapeutic Approaches:
There is a noticeable decrease in research focusing solely on traditional pharmacological therapies, such as older inhalers and medications, as more emphasis is placed on novel therapies and personalized medicine. - Basic Science Research:
The journal has seen a reduction in the publication of purely basic science studies that do not directly translate to clinical application, indicating a shift towards more clinically relevant research. - Single-Disease Focus Studies:
Research dedicated to single diseases without interdisciplinary approaches is waning, as the journal increasingly emphasizes studies that consider comorbid conditions and multifactorial influences on respiratory health.
Similar Journals
Respiratory Investigation
Advancing knowledge in Pulmonary and Respiratory Medicine.Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.
Minerva Respiratory Medicine
Unveiling breakthroughs in respiratory medicine.Minerva Respiratory Medicine is a prominent academic journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by EDIZIONI MINERVA MEDICA in Italy, this journal provides a vital platform for the dissemination of innovative research, clinical studies, and review articles that address the complexities of respiratory health. With an ISSN of 2784-8477 and an E-ISSN of 2724-6493, it serves as an open-access resource, allowing researchers, healthcare professionals, and students access to invaluable information without barriers. The journal is categorized in the fourth quartile of the 2023 rankings in the field of pulmonary and respiratory medicine, indicating its emerging role in the academic landscape. Despite its nascent status—converging from 2021 to 2024—Minerva Respiratory Medicine is committed to enhancing knowledge and practice in respiratory care, focusing on both innovative therapies and traditional approaches. With its aim to foster collaboration and communication among professionals in the field, this journal is an essential resource for those passionate about improving respiratory health outcomes.
RESPIRATORY MEDICINE
Exploring Breakthroughs in Lung HealthRespiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.
Egyptian Journal of Bronchology
Empowering knowledge exchange in bronchial medicine.Egyptian Journal of Bronchology, published by SPRINGER, is a premier open access journal dedicated to advancing the field of respiratory medicine, particularly focusing on bronchial diseases and disorders. Since its establishment in 2013, this journal has provided a platform for the dissemination of high-quality research articles, systematic reviews, and clinical studies, making significant contributions to the understanding and management of bronchological conditions. With its commitment to open access, the journal ensures that research findings are readily available to a global audience, fostering knowledge exchange among researchers, healthcare professionals, and students alike. The Egyptian Journal of Bronchology serves as an essential resource in the field, reflecting a growing emphasis on accessible scientific knowledge and collaborative research in respiratory health.
EUROPEAN RESPIRATORY JOURNAL
Uniting Experts in Respiratory AdvancementsThe EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.
Pulmonology
Elevating knowledge and practice in pulmonary medicine.Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.
Annals of the American Thoracic Society
Connecting researchers and clinicians for a healthier tomorrow.Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.
Lung India
Empowering knowledge for better lung care.Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.
RESPIROLOGY
Setting the Standard in Respiratory ResearchRESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.
RESPIRATION
Publishing Insights that Shape Respiratory MedicineRESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.